MaxID wins 1000-unit sale of iDL500 multi-modal mobile computer in South Africa

NewsGuard 100/100 Score

MaxID Pty Ltd, a wholly owned company of MaxID Corp, a leading provider of mobile identity solutions, is pleased to announce that it has won a 1000-unit sale of its iDL500 units in South Africa.

"MaxID, with its distribution partner, Pinnacle Technology Holdings Ltd Group, is capable of delivering a unique solution to the South Africa market.  Our iDL500, which is an incredibly proven device deployed in over a dozen countries, meets the advanced identity needs of the customers on this continent. MaxID devices are well-suited for the critical infrastructure market, the law enforcement market, homeland security and border protection markets.  These remain our primary markets we focus on with our solutions.  MaxID expects to deliver these devices rapidly over the 90-120 days," said Paul Miot, CEO of MaxID Pty Ltd.

"MaxID has one of the most durable, powerful and reliable handheld mobile devices for field-deployed identity.  We believe the MaxID products are extremely well-suited for the markets in Africa, and this award validates that.  The partnership between MaxID and Pinnacle continues to strengthen," said Mr. Takalani Tshivhase, Non-Executive Chairman of Pinnacle Africa.

The iDL500  is a multi-modal, rugged mobile computer that offers a complete set of features - including QWERTY keyboard, contact card, contactless card, barcode, optical fingerprint, and optional magnetic swipe and MRZ readers with a digital camera, GPS, and comprehensive communications capabilities such as 3G, GSM and WiFi. The iDL500 is a complete, integrated mobile solution for all field-based identity and fingerprint verification, field enrollment and identity management requirements.

Source:

MaxID Corp

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New study reveals lifestyle factors boosting IVF success